ABIGAIL WISELEY: Open Payments
NPI 1871131086 · CUMMING, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,859 in 98 payments from 21 companies in 2025. Trend: 2023 $2,759 · 2024 $2,600 · 2025 $2,859
Food & beverage: $2,751Education: $108
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $361 |
| ABBVIE INC. | 18 | $355 |
| GENZYME CORPORATION | 11 | $306 |
| Arcutis Biotherapeutics, Inc. | 4 | $252 |
| Galderma Laboratories, L.P. | 7 | $248 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $209 |
| MERZ NORTH AMERICA, INC. | 1 | $150 |
| Janssen Biotech, Inc. | 3 | $148 |
| Organon LLC | 5 | $148 |
| LEO Pharma Inc. | 5 | $132 |
Products named: DUPIXENT, SKYRIZI, Zoryve, NEMLUVIO, Xeomin, TREMFYA, VTAMA, ILUMYA.
Industry payments across GA — which companies pay providers there.
